Form 8.3 - Allergan Plc

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION
Name of person dealing (Note 1)Elliott Capital Advisors, L.P. (for itself and related general partners and investment managers)

 

Elliott International, L.P.
Elliott Associates, L.P.
Liverpool Limited Partnership
Company dealt inAllergan PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)Ordinary Shares: IE00BY9D5467
Date of dealing05/07/19
  1. INTERESTS AND SHORT POSITIONS
     
  2. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 LongShort
 Number (%)Number (%)
(1) Relevant securities  100  (0.00%) 
(2) Derivatives (other than options) 5,012,978  (1.529%) 
(3) Options and agreements to purchase/sell  250,000  (0.076%) 
Total 5,263,078  (1.605%) 
  1. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security:LongShort
 Number (%)Number (%)
(1) Relevant securities  
 

(2) Derivatives (other than options)
  
 

(3) Options and agreements to purchase/sell
  
Total  

 

Ap20

  1. DEALINGS (Note 4)
     
  2. Purchases and sales
 

Purchase/sale
 

Number of relevant securities
 

Price per unit (Note 5)
   
  1. Derivatives transactions (other than options transactions)
Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
Equity Swap

 

 
Reducing long

 
 7,201

 
$168.7165

 
  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)
       
  1. Exercising
Product name,

e.g. call option
Number of securitiesExercise price per unit (Note 5)
   
  1. Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction

(Note 8)
DetailsPrice per unit

(if applicable) (Note 5)
   

 

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            YES/NO

Date of disclosure08/07/19
Contact nameMichael Cross
Telephone number0203 009 1305
mcross@elliottadvisors.co.uk
If a connected EFM, name of offeree/offeror with which connected 
If a connected EFM, state nature of connection (Note 10) 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name,
e.g. call option
Written, or purchasedNumber of relevant securities to which the option or derivative relatesExercise price (Note 2)Type, e.g. American, European etc.Expiry date
Call OptionPurchased250,000132 USDAmerican16/08/19
      
      

Notes

1.          Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2.          For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.